Seaport Therapeutics Quarterly Balance Sheet
NASDAQ: SPTXHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Seaport Therapeutics financial position
As of Jun 30, 2026, Seaport Therapeutics reported total assets of $441.7 million against total liabilities of $19.1 million. Shareholders' equity stood at $422.6 million, or 95.7% of assets. The company held $64.2 million in cash and equivalents.
The current ratio (current assets divided by current liabilities) was 18.00, meaning short-term assets cover obligations due within a year.
Summary generated from market data by MetaCap's automated system. Methodology
Seaport Therapeutics balance sheet (quarterly)
| Quarter (USD) | Q2 20262026-06-30 | Q1 20262026-03-31 | Q? 20252025-06-30 | Q? 20252025-03-31 |
|---|---|---|---|---|
| Cash & Equivalents | 64.22M | 52.91M | — | — |
| Short-Term Investments | 209.09M | 129.70M | — | — |
| Total Current Assets | 282.18M | 188.34M | — | — |
| Property, Plant & Equipment | 360.00K | 386.00K | — | — |
| Long-Term Investments | 153.95M | 30.04M | — | — |
| Total Assets | 441.68M | 227.67M | — | — |
| Accounts Payable | 5.71M | 4.79M | — | — |
| Total Current Liabilities | 15.67M | 14.22M | — | — |
| Total Liabilities | 19.08M | 17.97M | — | — |
| Shareholders' Equity | 422.60M | -115.62M | -49.55M | -36.16M |
| Retained Earnings | -202.12M | -139.52M | — | — |
| Net Cash (Debt) | 273.31M | 182.60M | — | — |
| Shares Outstanding | 53.53M | 2.60M | — | — |
This table shows 4 quarterly periods of Seaport Therapeutics's balance sheet, from Q2 2026 back to Q? 2025, across 13 line items including cash & equivalents, short-term investments, total current assets. Values in USD; B = billions, M = millions. Fiscal periods follow SPTX's reporting calendar. What is a balance sheet?